Skip to search formSkip to main contentSkip to account menu

pamiteplase

Known as: 275-L-Glutamic Acid-(1-91)-(174-527)-Plasminogen Activator (Human Tissue-Type Protein Moiety) 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Recombinant Proteinsalteplase

Narrower (1)

YM 866

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
THROMBOLYTIC & CYTOTOXIC EFFECT OF DIFFERENT HERBAL EXTRACTS
An in-vitro thrombolytic model was used to check the clot lysis effect of four herbal extracts viz., Honey, Nigella sativa… 
2008
2008
Analysis of cell-cycle-dependent production of tissue plasminogen activator analogue (pamiteplase) by CHO cells
2007
2007
Comparison of Effects between Alteplase and Pamiteplase on MMPs Regulation
Thrombolytic therapy with tissue plasminogen activator (tPA) can improve the clinical outcome of ischemic stroke patients… 
2003
2003
Reduction of infarction volume by bolus injection of pamiteplase, a modified tissue plasminogen activator with a longer half-life
Abstract Using a rat model of thromboembolic stroke we evaluated whether or not fibrinolysis by bolus injection of pamiteplase, a… 
2001
2001
Pharmacokinetic properties of a novel tissue-type plasminogen activator pamiteplase after single intravenous administration to rats, dogs, and monkeys.
2000
2000
Determination, pharmacokinetics and protein binding of a novel tissue-type plasminogen activator, pamiteplase in human plasma
1. An enzyme-linked immunosorbent assay (ELISA) and functional bioassay to determine immunoreactive and bioactive concentrations… 
2000
2000
Comparison of receptor-mediated endocytosis kinetics between wild-type t-PA and recombinant pamiteplase in isolated rat hepatocytes and liver cell plasma membranes
1. Differences in receptor-mediated endocytosis kinetics between pamiteplase, an engineered t-PA, and an unmodified rt-PA were… 
Review
2000
Review
2000
[Research and development of novel modified tissue-type plasminogen activator (t-PA), pamiteplase].
Tissue-type plasminogen activator (t-PA) is a potent thrombolytic agent that, owing to its strict fibrin specificity, is superior… 
1999
1999
Monosaccharide composition analysis of pamiteplase by anion exchange chromatography with pulsed amperometric detection.
1997
1997
Reproductive toxicity, mutagenicity and antigenicity of pamiteplase (genetical recombination).
Pamiteplase (genetical recombination), YM866, is a novel recombinant modified human tissue-type plasminogen activator developed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)